Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04873609 · ClinicalTrials.gov registry record · NA
Electronic Record Assimilation and Subsequent Eradication of Hepatitis C
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
NCT04873609: Completed NA study, sponsored by Stanford University.
NCT04873609 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04873609, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
Study Summary
Given the disproportionately high risk of chronic hepatitis C virus (HCV) infection in the baby boomer cohort, population-based screening has been demonstrated cost effective. Compared to point-of-care testing, however, bulk health messages with coupled lab requisitions delivered directly to patients meeting screening criteria via patient portals could improve HCV screening at minimal cost.
Interventions
- BEHAVIORAL Patient portal message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04873609
The ClinicalTrials.gov registry entry for NCT04873609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient portal message is the first listed.
NCT04873609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04873609 about?
NCT04873609 is a clinical study titled "Electronic Record Assimilation and Subsequent Eradication of Hepatitis C". Given the disproportionately high risk of chronic hepatitis C virus (HCV) infection in the baby boomer cohort, population-based screening has been demonstrated cost effective. Compared to point-of-care testing, however, bulk health messages with coupled lab requisitions delivered directly to patient...
What is the current status of trial NCT04873609?
This trial is currently completed. It is a NA study. The enrollment target is 1,600 participants. The study started on 2019-05-01. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT04873609?
The interventions under investigation include: Patient portal message (BEHAVIORAL).
Who is sponsoring clinical trial NCT04873609?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.